Clinical Trial Update: Goserelin and Letrozole or Anastrozole in Premenopausal Patients With Stage II-III Estrogen Receptor-Positive Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating goserelin with letrozole or anastrozole in premenopausal women with stage II-III estrogen receptor-positive breast cancer; terminated w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Estrogen Receptor-positive Breast Cancer
• Stage Iiia Breast Cancer
• Stage Iiib Breast Cancer
• Stage Iiic Breast Cancer

Drugs mentioned

• ARIMIDEX (anastrozole)
• FEMARA (letrozole)
• Zoladex (goserelin)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer | Phase 2 | Status: TERMINATED | Results posted: 2015-02-20